Weight-loss landing page audits.
Weight loss is the category the GLP-1 era rewrote in 18 months. The ad sells a number on a scale; the page sells an eligibility quiz, a disclaimer block, and a compounded-versus-branded distinction the visitor did not know existed. The audits in this hub grade real weight-loss ads against their real landing pages on a published four-dimension rubric.
// Category · Weight loss
Overview.
Weight loss now covers GLP-1 telehealth (semaglutide, tirzepatide, compounded variants), program-based coaching, supplement-led pitches, and the surviving long tail of meal-replacement and app-only motions. The unifying property for message match: the ad sells a result, the page sells a screening process, and the seam between them is where the click leaks.
The seam is also where the regulator lives. FTC weight-loss guidance, state-level telehealth rules, and platform-specific creative policies all shape what the ad can promise and what the page must qualify. A page that earns a high score here is not necessarily the most aggressive page; it is the page where the qualified promise above the fold matches the qualified promise the ad already made.
What we grade in weight loss.
Every audit in this hub runs the same four-dimension rubric documented in the methodology. The substance of a weight-loss audit is whether the page's above-the-fold pays back the specific promise the ad made, with the specific qualifications the ad attached, in the specific language the visitor just read.
- ↳
Headline echo against the result the ad promised. If the ad says "lose 20 lbs in 3 months," the H1 should confirm the outcome category ("weight loss with GLP-1," "medically supervised weight loss") rather than swap to a brand statement. A generic "meet your healthiest self" H1 abandons the click.
- ↳
Offer continuity through the eligibility quiz. If the ad implied immediate access, the page's primary CTA should begin the quiz, not route to a marketing page. If the ad promised a price, the price should appear before the quiz, not at quiz-end.
- ↳
Disclosure placement that does not contradict the ad. FTC-driven disclaimers about typical results, prescription requirements, and compounded-versus-branded distinction are mandatory. The audit grades whether they accompany the promise above the fold or hide it below.
- ↳
Scent confirmation for the medication or program. An ad referencing semaglutide should not land on a page that only says "GLP-1." An ad for a coaching program should not land on a medication-led hero. The visitor needs to recognize the thing they clicked on inside the first viewport.
Common failure modes.
The mismatches in weight loss are not subtle. They repeat across hundreds of audits because the same structural pressure produces them: an ad written to move on a feed, a page written to survive review, and a quiz designed to collect a card.
- ↳
Compounded-versus-branded ambiguity. The ad shows what reads as branded medication imagery. The page sells compounded semaglutide. Neither piece is wrong on its own; the visitor cannot tell which one they are about to buy until step four of the quiz.
- ↳
Result claim above the fold of the ad, disclaimer below the fold of the page. The ad headline is the number. The page hero is brand-led. The qualifier the ad legally needed sits in section three. The visitor reads the promise on the ad and never sees the page version of it.
- ↳
Quiz-first CTA on a research-stage click. The visitor clicked to learn whether they qualify. The page's only above-the-fold action is "start your quiz." There is no eligibility summary, no medication detail, no price. The friction is the offer.
- ↳
Before/after imagery without the disclosure beside it. FTC guidance ties typical-results language to the imagery, not the footer. Pages that load the image at the top and the disclosure at the bottom break the link the visitor was supposed to see.
- ↳
Spanish-creative-to-English-page drift. Weight-loss advertisers run heavy Spanish-language creative on Meta. The landing page is English-only. Continuity dies at the language switch even when the hero copy would otherwise match.
Notes by platform.
Weight-loss paid acquisition runs primarily on Meta and Google, with a heavier Meta lean than most healthcare categories. Each platform stresses a different dimension of the rubric. The patterns below are the ones specific to weight loss.
- ↳
Google (paid search). Headline echo dominates. The query carries the medication name or the result ("semaglutide near me," "GLP-1 cost"). The H1 that swaps in a brand statement is the most common failure here.
- ↳
Meta. Visual and tonal continuity dominate. Meta weight-loss creative leans before/after imagery, transformation footage, and urgent results copy. The page often pivots to clinical typography and program language. The whiplash is the audit.
- ↳
LinkedIn. Weight-loss advertising is rare on LinkedIn outside of corporate-benefits pitches. When it appears, offer continuity dominates: a benefits-led ad should not land on a consumer-quiz hero.
Audits in this hub.
Audits in this category roll into this hub as they pass the quality gate. Browse the full audit library while it fills, or grade your own ad.
Frequently asked questions.
What counts as a weight-loss audit?▸
Any audit where the advertiser sells a weight-loss outcome, medication, program, or supplement direct to a consumer. The umbrella spans GLP-1 telehealth (branded and compounded), medically supervised programs, coaching subscriptions, meal-replacement systems, and supplement-led pitches. Fitness-app-led weight-loss positioning is graded in the fitness-apps hub.
How do you score FTC-style disclaimers above the fold?▸
The rubric never penalizes the presence of a required disclaimer. What it grades is whether the disclaimer accompanies the claim it qualifies. "Typical results not guaranteed" sitting two screens below the headline that promised twenty pounds is a continuity failure on the page, not a compliance failure.
Do you grade the medical accuracy of weight-loss claims?▸
No. PostClickSignal scores the message-match relationship between the ad and the page. Medical accuracy, prescribing appropriateness, and clinical evidence sit outside the rubric. We will note when the ad and page disagree about which medication is being sold; we will not adjudicate the medication.
How do you handle compounded-versus-branded ambiguity?▸
We note it as a scent failure when the ad creative implies one and the page sells the other. A compounded-only page that runs visually-branded creative is a confirmation problem; the visitor cannot recognize the product they are about to buy. We do not score the legality of the positioning.
Why does Spanish-to-English drift show up so often?▸
Because weight-loss advertisers segment heavily on Spanish-language audiences on Meta and rarely build matching landing pages. The ad runs in Spanish and the page renders in English. The continuity break is mechanical, not editorial, and it shows up across many advertisers in this category.